AstraZeneca Pharma jumps after turnaround Q4 result

AstraZeneca Pharma India gained 12.41% to Rs 964.50 at 09:50 IST on BSE after the company reported net profit of Rs 38.13 crore in Q4 March 2015 as against net loss of Rs 2.57 crore in Q4 March 2014.

The result was announced after market hours yesterday, 27 May 2015.

Meanwhile, the S&P BSE Sensex was up 23.38 points or 0.08% at 27,588.04

On BSE, so far 28,511 shares were traded in the counter as against average daily volume of 5,562 shares in the past one quarter.

The stock hit a high of Rs 1,009.75 and a low of Rs 952.75 so far during the day. The stock had hit a 52-week low of Rs 785.30 on 17 December 2014. The stock had hit a 52-week high of Rs 1,245 on 23 June 2014.

The small-cap company has equity capital of Rs 5 crore. Face value per share is Rs 2.

AstraZeneca Pharma India's total income rose 31.2% to Rs 169.90 crore in Q4 March 2015 over Q4 March 2014.

AstraZeneca Pharma India is one of the leading pharmaceutical companies, with a broad range of medicines designed to fight disease in important areas of healthcare. The company is involved in both manufacturing and marketing of medicines.

Powered by Capital Market - Live News